Nanochon Performs First Case in the Chondrograft™ First in Human Clinical Study
Baltimore, MD, September 2, 2026 – Nanochon, a cultivate(MD) portfolio company developing Chondrograft™, a novel 3D-printed patented implant for the treatment of articular cartilage defects of the knee, today announced the successful treatment of the first patient in its First-in-Human (FIH) clinical study. The study is designed to evaluate the safety and performance of Chondrograft™ […]
Nanochon Performs First Case in the Chondrograft™ First in Human Clinical Study Read More »